Skip to main content
OpenTrials

Clinical trial condition

Drug/Agent Toxicity by Tissue/Organ

Explore clinical trials studying Drug/Agent Toxicity by Tissue/Organ. Study availability and eligibility vary by location and protocol.

30 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Drug/Agent Toxicity by Tissue/Organ trial results

Completed

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

NCT00400946

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT00093353

Conditions
Chemically-Induced Disorders, Diarrhea, Drug-Related Side Effects and Adverse Reactions, +14 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Completed

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

NCT00296036

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 231 locations
View Trial Details
Completed

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

NCT00003600

Conditions
Anemia, Blood Protein Disorders, Bone Marrow Diseases, +39 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Howard University Cancer Center Washington D.C., District of Columbia, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
View all 21 locations
View Trial Details
Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

NCT00006012

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
View all 84 locations
View Trial Details
Completed

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00077311

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +25 more
Locations
  • El Camino Hospital Mountain View, California, United States
  • Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • St. Francis Hospital Wilmington, Delaware, United States
View all 64 locations
View Trial Details
Completed

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

NCT00075868

Conditions
Anal Cancer, Anus Diseases, Anus Neoplasms, +17 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Foundation for Cancer Research and Education Phoenix, Arizona, United States
  • Enloe Cancer Center at Enloe Medical Center Chico, California, United States
  • Saint Agnes Medical Center Fresno, California, United States
View all 112 locations
View Trial Details
Completed

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

NCT00003313

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Huntsville Hospital System Huntsville, Alabama, United States
  • Comprehensive Cancer Institute of Huntsville Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
View all 264 locations
View Trial Details

Related conditions